Graves' disease other diagnostic studies

Graves' disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Graves' disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Approach
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy Hyperthyroidism Ophtalmopathy Dermopathy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Graves' disease other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Graves' disease other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Graves' disease other diagnostic studies
CDC on Graves' disease other diagnostic studies
Graves' disease other diagnostic studies in the news
Blogs on Graves' disease other diagnostic studies
Directions to Hospitals Treating Graves' disease
Risk calculators and risk factors for Graves' disease other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Increased homogenous radioactive iodine uptake is diagnostic for graves' disease.

Radioactive iodine uptake

24-hr radioactive iodine uptake (RAIU) is a diagnostic measure for Graves' disease which shows increased homogeneous uptake.